title: GATA3 expression is decreased in psoriasis and during epidermal regeneration; induction by narrow-band UVB and IL-4.
abstract: Psoriasis is characterized by hyperproliferation of keratinocytes and by infiltration of activated Th1 and Th17 cells in the (epi)dermis. By expression microarray, we previously found the GATA3 transcription factor significantly downregulated in lesional psoriatic skin. Since GATA3 serves as a key switch in both epidermal and T helper cell differentiation, we investigated its function in psoriasis. Because psoriatic skin inflammation shares many characteristics of epidermal regeneration during wound healing, we also studied GATA3 expression under such conditions.Psoriatic lesional skin showed decreased GATA3 mRNA and protein expression compared to non-lesional skin. GATA3 expression was also markedly decreased in inflamed skin of mice with a psoriasiform dermatitis induced with imiquimod. Tape-stripping of non-lesional skin of patients with psoriasis, a standardized psoriasis-triggering and skin regeneration-inducing technique, reduced the expression of GATA3. In wounded skin of mice, low GATA3 mRNA and protein expression was detected. Taken together, GATA3 expression is downregulated under regenerative and inflammatory hyperproliferative skin conditions. GATA3 expression could be re-induced by successful narrow-band UVB treatment of both human psoriasis and imiquimod-induced psoriasiform dermatitis in mice. The prototypic Th2 cytokine IL-4 was the only cytokine capable of inducing GATA3 in skin explants from healthy donors. Based on these findings we argue that GATA3 serves as a key regulator in psoriatic inflammation, keratinocyte hyperproliferation and skin barrier dysfunction.
authors: Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
authors: Emoke
authors: E
authors: Rácz
authors: Dorota
authors: D
authors: Kurek
authors: Marius
authors: M
authors: Kant
authors: Ewout M
authors: EM
authors: Baerveldt
authors: Edwin
authors: E
authors: Florencia
authors: Sabine
authors: S
authors: Mourits
authors: Dick
authors: D
authors: de Ridder
authors: Jon D
authors: JD
authors: Laman
authors: Leslie
authors: L
authors: van der Fits
authors: Errol P
authors: EP
authors: Prens
references: Eur J Immunol. 2008 Nov;38(11):3138-49
references: 18924208
references: J Immunol. 2004 Jan 15;172(2):1099-108
references: 14707084
references: J Pathol. 2003 Jan;199(1):107-14
references: 12474233
references: Br J Dermatol. 2004 Oct;151(4):746-52
references: 15491413
references: Genes Dev. 2003 Sep 1;17(17):2108-22
references: 12923059
references: Cell. 1997 May 16;89(4):587-96
references: 9160750
references: Dev Dyn. 2007 Jan;236(1):226-39
references: 17089409
references: J Invest Dermatol. 1996 Oct;107(4):558-64
references: 8823361
references: Br J Dermatol. 2008 Jun;158(6):1315-22
references: 18410415
references: J Invest Dermatol. 2006 Apr;126(4):869-81
references: 16470182
references: Am J Pathol. 1996 May;148(5):1493-502
references: 8623919
references: J Biol Chem. 2009 Mar 27;284(13):8217-21
references: 19008218
references: Expert Opin Ther Targets. 2007 Jul;11(7):955-65
references: 17614763
references: Nat Genet. 1995 Sep;11(1):40-4
references: 7550312
references: J Exp Med. 2005 Jun 6;201(11):1715-23
references: 15928199
references: Nat Genet. 2009 Feb;41(2):199-204
references: 19169254
references: Eur J Immunol. 1999 Jun;29(6):1912-8
references: 10382753
references: Immunity. 1998 Nov;9(5):745-55
references: 9846495
references: J Investig Dermatol Symp Proc. 2006 Sep;11(1):16-29
references: 17069007
references: Development. 1994 Sep;120(9):2673-86
references: 7956841
references: J Exp Med. 2005 Jul 4;202(1):135-43
references: 15998792
references: Arch Dermatol Res. 2001 Apr;293(4):184-90
references: 11380151
references: Biochem Biophys Res Commun. 2007 Sep 14;361(1):1-6
references: 17632082
references: Biostatistics. 2003 Apr;4(2):249-64
references: 12925520
references: Neurobiol Dis. 2004 Jun;16(1):169-78
references: 15207274
references: J Biol Chem. 1997 Aug 22;272(34):21597-603
references: 9261181
references: Br J Dermatol. 2007 Feb;156(2):231-40
references: 17223861
references: J Cell Biol. 2006 Nov 20;175(4):661-70
references: 17116754
references: Nat Med. 2003 Jan;9(1):40-6
references: 12461524
references: Immunol Rev. 2006 Feb;209:47-57
references: 16448533
references: Genome Biol. 2003;4(5):P3
references: 12734009
references: Dev Immunol. 1992;3(1):1-11
references: 1343100
references: Genes Dev. 2008 Apr 15;22(8):976-85
references: 18413712
references: J Invest Dermatol. 2011 Jul;131(7):1547-58
references: 21412260
references: Oncogene. 2008 Apr 7;27(16):2320-36
references: 18391974
references: Development. 2007 Jan;134(2):261-72
references: 17151017
references: J Invest Dermatol. 2008 Apr;128(4):932-8
references: 17928888
references: Skin Res Technol. 2001 Feb;7(1):40-8
references: 11301640
references: Pharmacogenomics J. 2001;1(4):272-87
references: 11911124
references: Gene. 2009 May 1;436(1-2):121-7
references: 19232384
references: Clin Dermatol. 2007 Nov-Dec;25(6):589-95
references: 18021897
references: J Invest Dermatol. 2007 Jan;127(1):163-9
references: 16858420
references: Bioinformatics. 2003 Jan 22;19(2):185-93
references: 12538238
references: Genes Dev. 1990 Oct;4(10):1650-62
references: 2249770
references: J Biol Chem. 2009 Jun 26;284(26):17766-74
references: 19398556
references: Immunity. 2000 Jan;12(1):27-37
references: 10661403
references: J Immunol. 2009 May 1;182(9):5836-45
references: 19380832
references: Physiol Genomics. 2003 Mar 18;13(1):69-78
references: 12644634